| Neonatal Health and Biochemistry | Lifetime | 36 | US 21 | 99.26 |
| Hemoglobinopathies and Related Disorders | Lifetime | 82 | US 40 | 99.15 |
| Neonatal Respiratory Health Research | Lifetime | 166 | US 84 | 99.33 |
| Blood disorders and treatments | Lifetime | 50 | US 29 | 99.02 |
| Erythrocyte Function and Pathophysiology | Lifetime | 109 | US 71 | 98.85 |
| Neonatal and Maternal Infections | Lifetime | 34 | US 24 | 99.07 |
| Blood groups and transfusion | Lifetime | 114 | US 53 | 98.78 |
| Infant Nutrition and Health | Lifetime | 93 | US 37 | 98.86 |
| Blood transfusion and management | Lifetime | 84 | US 43 | 98.24 |
| Sepsis Diagnosis and Treatment | Lifetime | 271 | US 104 | 98.75 |
| Immune Response and Inflammation | Lifetime | 588 | US 276 | 98.56 |
| Neutropenia and Cancer Infections | Lifetime | 164 | US 83 | 98.27 |
| Erythropoietin and Anemia Treatment | Lifetime | 100 | US 45 | 98.13 |
| Platelet Disorders and Treatments | Lifetime | 351 | US 139 | 97.94 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 23 | US 18 | 97.52 |
| Neonatal and fetal brain pathology | Lifetime | 364 | US 169 | 97.75 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 320 | US 155 | 96.07 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 473 | US 216 | 96.10 |
| Iron Metabolism and Disorders | Lifetime | 738 | US 318 | 96.14 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 816 | US 368 | 93.12 |
| Neonatal Health and Biochemistry | 2021-2025 | 17 | US 8 | 96.37 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 195 | US 99 | 95.12 |
| Blood groups and transfusion | 2021-2025 | 165 | US 57 | 92.60 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 135 | US 52 | 90.60 |
| Neonatal Respiratory Health Research | 2021-2025 | 728 | US 255 | 92.37 |
| Iron Metabolism and Disorders | 2021-2025 | 440 | US 160 | 88.10 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 222 | US 43 | 81.74 |
| Neonatal and fetal brain pathology | 2021-2025 | 820 | US 263 | 82.35 |
| Blood transfusion and management | 2021-2025 | 360 | US 153 | 77.65 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 530 | US 198 | 71.08 |
| Methemoglobinemia and Tumor Lysis Syndrome | 2021-2025 | 60 | US 14 | 67.55 |
